Marcus Skribek

Om mig
Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Om mig

För detaljerad information, se den engelska presentationssidan.

Artiklar

Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2025;43(16_SUPPL):2024
Irradiated tumor volume as a predictor of local recurrence and radionecrosis in lung cancer with brain metastases treated with stereotactic radiosurgery.
Koulouris A; Grundberg O; Skribek M; Kamali C; Gubanski M; Ekman S; Tsakonas G
Article: LUNG CANCER. 2025;199:108065
A novel clinical brain prognostic index for KRAS-mutated lung cancer and brain metastases (KRAS-BPI): Real-world evidence from two large European centers
Zerdes I; Kamali C; Johannsdottir B; Blasi M; Assmann C; Kazdal D; Stenzinger A; Skribek M; Ekman S; Christopoulos P; Tsakonas G
Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2024;74(1):14
Differences in immune-related toxicity between PD-1 and PD-L1 inhibitors: a retrospective cohort study in patients with advanced cancer
Ladjevardi CO; Skribek M; Koliadi A; Ryden V; El-Naggar AI; Digkas E; Valachis A; Ullenhag GJ
Journal article: ANNALS OF ONCOLOGY. 2024;35:s858
The Stereotactic Radiosurgery-Brain Prognostic Index (SRS-BPI): A novel prognostic index for lung cancer patients with brain metastases eligible for SRS
Koulouris AV; Skribek MC; Kamali C; Grundberg O; Lampa E; Gubanski M; Hydbring P; Ekman S; Tsakonas G
Article: EUROPEAN JOURNAL OF RADIOLOGY. 2024;177:111557
Diffusion weighted MRI and apparent diffusion coefficient as a prognostic biomarker in evaluating chemotherapy-antiangiogenic treated stage IV non-small cell lung cancer: A prospective, single-arm, open-label, clinical trial (BevMar)
Grundberg O; Skribek M; Swerkersson S; Skorpil M; Kolbeck K; Grozman V; Nyren S; Tsakonas G
Article: ACTA ONCOLOGICA. 2023;62(12):1808-1814
Real-world analysis of MET exon 14 mutations in non-small cell lung cancer: a retrospective study from two Swedish hospitals
Skribek M; Brunnstrom H; Oskarsdottir G; Grive MP; Aricak O; Planck M; Jatta K; Naserhojati H; de Flon FH; Ekman S
Journal article: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s638
EP11.03-40 An Observational Study to Identify Selection Criteria for Initiation of Different First Line Treatment Options in NSCLC Patients
Skribek M; Sierakowiak A; Koulouris A; Rounis K; Goenechea J; Labor M; Lund HW; Axelsson I; Fornwall A; Tsakonas G; Koyi H
Article: LUNG CANCER. 2022;166:132-134
Osimertinib-induced syndrome of inappropriate secretion of antidiuretic hormone in oncogene-addicted lung adenocarcinoma: A case report
Skribek M; Bozoky B; Tsakonas G
Article: CANCERS. 2021;13(7):1562
Correlation of Clinical Parameters with Intracranial Outcome in Non-Small Cell Lung Cancer Patients with Brain Metastases Treated with Pd-1/Pd-L1 Inhibitors as Monotherapy
Rounis K; Skribek M; Makrakis D; De Petris L; Agelaki S; Ekman S; Tsakonas G
Article: EUROPEAN JOURNAL OF CANCER. 2021;145:245-254
Effect of corticosteroids on the outcome of patients with advanced non-small cell lung cancer treated with immune-checkpoint inhibitors
Skribek M; Rounis K; Afshar S; Grundberg O; Friesland S; Tsakonas G; Ekman S; De Petris L
Article: CANCERS. 2020;12(12):E3707-3707
Outcome of Patients with NSCLC and Brain Metastases Treated with Immune Checkpoint Inhibitors in a 'Real-Life' Setting
Skribek M; Rounis K; Makrakis D; Agelaki S; Mavroudis D; De Petris L; Ekman S; Tsakonas G

Alla övriga publikationer

Review: CANCERS. 2025;17(6):986
Ex-Vivo Drug-Sensitivity Testing to Predict Clinical Response in Non-Small Cell Lung Cancer and Pleural Mesothelioma: A Systematic Review and Narrative Synthesis
Zipprick J; Demir E; Krynska H; Kopruluoglu S; Strauss K; Skribek M; Otvos RH-G; Gad AKB; Dobra K
Thesis / dissertation: KAROLINSKA INSTITUTET. 2024
Strategies for optimizing immune checkpoint inhibition in advanced non-small cell lung cancer
Skribek M
Doctoral thesis: 2024
Strategies for optimizing immune checkpoint inhibition in advanced non-small cell lung cancer
Skribek M
Thesis / dissertation: KAROLINSKA INSTITUTET. 2024
Strategies for optimizing immune checkpoint inhibition in advanced non-small cell lung cancer
Skribek M
Preprint: MEDRXIV. 2024
The Brain-Lung Immunotherapy Prognostic (BLIP) Score: A Novel Robust Tool for Prognostication in Non-Small Cell Lung Cancer Patients with Brain Metastases
Skribek M; Livanou M-E; Vathiotis I; Strandman V; Thorell A; Koulouris A; Syrigos K; Ekman S; Tsakonas G
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):s599
EP09.04-01 Prognostic Factors for Patients With KRAS Mutated Non-Small Cell Lung Cancer and Brain Metastases
Tsakonas G; Skribek M; Kamali C; Zerdes I; Jóhannsdóttir B; Ekman S
Review: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2023;11(3):e005841
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature
Liu LL; Skribek M; Harmenberg U; Gerling M
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S638
An Observational Study to Identify Selection Criteria for Initiation of Different First Line Treatment Options in NSCLC Patients
Skribek M; Sierakowiak A; Koulouris A; Rounis K; Goenechea J; Labor M; Lund HW; Axelsson I; Fornwall A; Tsakonas G; Koyi H
Conference publication: JOURNAL OF THORACIC ONCOLOGY. 2023;18(11):S599
Prognostic Factors for Patients With KRAS Mutated Non-Small Cell Lung Cancer and Brain Metastases
Tsakonas G; Skribek M; Kamali C; Zerdes I; Johannsdottir B; Ekman S
Conference publication: ANNALS OF ONCOLOGY. 2022;33(7):S1087
Real-world insights into non-small cell lung cancer patients with MET exon 14 skipping mutations: A Swedish retrospective study from two university hospitals
Skribek M; Brunnstrom H; Aricak O; Planck M; Jatta K; Oskarsdottir GN; Naserhojati H; Haglund F; Ekman S
Preprint: MEDRXIV. 2022
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: Systematic review of the literature
Liu L; Skribek M; Harmenberg U; Gerling M
Review: JOURNAL OF INTERNAL MEDICINE. 2022;291(6):732-754
Complications following novel therapies for non-small cell lung cancer
Skribek M; Rounis K; Tsakonas G; Ekman S

Forskningsbidrag

Research Grant
Radiumhemmets Forskningsfonder
1 June 2022 - 31 May 2024

Anställningar

Anknuten till Forskning, Onkologi-Patologi, Karolinska Institutet, 2023-2026
Resident Oncologist, Theme Cancer, Karolinska University Hospital, 2019-2025
Doctoral Student, Department of Oncology-Pathology, Karolinska Institutet, 2022-2024

Examina och utbildning

Doctor of Philosophy (Ph.D.), Strategies for optimizing immune checkpoint inhibition in advanced non-small cell lung cancer, Department of Oncology-Pathology, Karolinska Institutet, 2024
Medical Doctor (M.D.), Faculty of Medicine, Semmelweis University, 2018
Medical Doctor (M.D.), Faculty of Medicine, University of Pecs, 2014

Uppdrag

Prefekt, Acting Head of the Lung Cancer Department, Theme Cancer, Karolinska University Hospital, 2025-2025

Gästforskning och resestipendier

Clinical Research Fellow, Memorial Sloan Kettering Cancer Center, - Joined MSKCC to deepen expertise in oncology through firsthand learning of cancer management and treatment practices. - Collaborated with multidisciplinary teams to enhance patient outcomes and advance cancer care methodologies. - Specialized in radiotheranostics at the Jason Lewis Lab, integrating diagnostic imaging and targeted therapy to develop precision medicine approaches. - Involved in research focusing on DLL3 in small cell lung cancer and DLK1 in sarcoma, aiming to develop effective therapies for aggressive cancer types. - Worked under the supervision of industry-leading experts to pioneer novel cancer therapy methods., 2024-2024

Konferenser och events

Poster-presentationer av egna accepterade abstract, European Society for Medical Oncology (ESMO), 2022

Om mig

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Examina och utbildning

Uppdrag

Gästforskning och resestipendier

Konferenser och events

Nyheter från KI

Kalenderhändelser från KI